NEXN vs RGNX
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
NEXN · Nexxen International$8.84 ▼ 1.45%
RGNX · Regenxbio$7.62 ▲ 3.25%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- NEXN +15.7%
- RGNX -30.9%
Head to head
| Metric | NEXN | RGNX |
|---|---|---|
| Price | $8.84 | $7.62 |
| Change today | ▼ 1.45% | ▲ 3.25% |
| Market cap | $503.45M | $503.85M |
| Return, 3 months | -17.8% | -26.9% |
| Return, year to date | +35.2% | -47.1% |
| Return, 1 year | +15.3% | -32.0% |
| P/E (TTM) | 40.2 | – |
| P/B | 1.1 | 3.4 |
| P/E percentile vs own 5y | 91st | 66th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +10.5% | +405.7% |
| Net profit growth (YoY) | -58.0% | +132.0% |
| Gross margin | 82.5% | 86.4% |
| Operating margin | 5.1% | -94.1% |
| Net margin | 3.4% | -112.6% |
| Return on equity | 2.7% | -137.6% |
| Analyst target vs. price | +51.9% | +181.5% |
| Analyst buy share | 100% | 82% |
| RSI (14) | 48 | 52 |
| 30-day volatility | 29.7% | 62.8% |
| Max drawdown, 1 year | -32.9% | -64.6% |
| Trend read | Leaning bearish | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- RGNX is the largest of the group by market value.
- NEXN has returned the most over the past year.
- RGNX is growing revenue fastest.
- NEXN keeps the most profit per dollar of sales.
- NEXN has been the calmest stock over the last 30 days.